Avidity Biosciences Says Lead Program Shows Reversal Of Disease Progression In Neuromuscular Disease
Monday, Avidity Biosciences Inc (NASDAQ:RNA) revealed new long-term AOC 1001 data from the MARINA open-label extension (MARINA-OLE) trial showing reversal of disease progression in myotonic dystrophy ...
A weak hand grip isn't just a sign of weakness or ageing related issues but could be an indicator of a range of health troubles from type 2 diabetes, cardiovascular issues, stroke, kidney and liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results